Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year
Completed
Sanofi
Phase 3
The purpose of the study is to assess efficacy and safety of eplivanserin in the population
of patients complaining of sleep maintenance insomnia. The patients suffering from that
condition frequently wake up during the night, their sleep is nonrestorative and they suffer
from a significant distress or impairment in their daily activities consecutive to insomnia.
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Completed
Sanofi
Phase 3
The purpose of the study is to assess efficacy and safety of eplivanserin in the population
of patients complaining of sleep maintenance insomnia. The patients suffering from that
condition frequently wake up during the night, their sleep is nonrestorative and they suffer
from a significant distress or impairment in their daily activities consecutive to insomnia.
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia
Completed
Sanofi
Phase 3
The aim of the study is to confirm the efficacy of eplivanserin 5mg/day on sleep maintenance
of patients with primary insomnia using night polysomnography recordings over a 6-week
treatment period corresponding to a stabilization of improvement of sleep.
Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia
Completed
Sanofi
Phase 2
Fibromyalgics frequently report sleep disturbances, in particular poor and unrefreshing
sleep. Additionally, studies have reported that sleep problems, pain and mood disturbances
are associated in patients with fibromyalgia. By improving the quality of sleep, complaints
of poor and unrefreshing sleep, fatigue, pain, which are among the main components of this
chronic pain disorder may be improved.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.